HLA-DRB1 differences in allelic distribution between familial and sporadic multiple sclerosis in a Hellenic cohort

References

• Patsopoulos NA, Barcellos LF, Hintzen RQ, et al. Fine-mapping the genetic association of the major histocompatibility complex in multiple sclerosis: HLA and non-HLA effects. PLoS Genet. 2013;9(11):e1003926.
   PubMed Web of Science ®Google Scholar
• Artemiadis AK, Anagnostouli MC. Apoptosis of oligodendrocytes and post-translational modifications of myelin basic protein in multiple sclerosis: possible role for the early stages of multiple sclerosis. Eur Neurol. 2010;63(2):65–72.
   PubMed Web of Science ®Google Scholar
• Ramagopalan S, Maugeri N, Handunnetthi L, et al. Expression of the multiple sclerosis associated MHC class II allele HLA-DRB1*1501 is regulated by vitamin D. PLoS Genet. 2009;5:e1000369.
   PubMed Web of Science ®Google Scholar
• Planas R, Santos R, Tomas-Ojer P, et al. GDP-l-fucose synthase is a CD4+ T cell-specific autoantigen in DRB3*02:02 patients with multiple sclerosis. Sci Transl Med. 2018;10(462). DOI:10.1126/scitranslmed.aat4301
   PubMed Web of Science ®Google Scholar
• Kakalacheva K, Münz C, Lünemann JD. Viral triggers of multiple sclerosis. Biochim Biophys Acta. 2011;1812(2):132–140.
   PubMed Web of Science ®Google Scholar
• Nielsen TR, Rostgaard K, Askling J, et al. Effects of infectious mononucleosis and HLA-DRB1*15 in multiple sclerosis. Mult Scler. 2009;15:431–436.
   PubMed Web of Science ®Google Scholar
• Nato S, Namerow N, Mickey MR, et al. Multiple sclerosis: association with HL-A3. Tissue Antigens. 1972;2:1–4.
   PubMedGoogle Scholar
• Harirchian MH, Fatehi F, Sarraf P, et al. Worldwide prevalence of familial multiple sclerosis: a systematic review and meta-analysis. Mult Scler Relat Disord. 2018;20:43–47.
   PubMed Web of Science ®Google Scholar
• Sadovnick AD, Baird PA. Multiple sclerosis: updated risks for relatives. Am J Med Genet. 1988;29:533–541.
   PubMed Web of Science ®Google Scholar
• Olerup O, Hillert J. HLA class II-associated genetic susceptibility in multiple sclerosis: a critical evaluation. Tissue Antigens. 1995;38:1–15.
   Google Scholar
• Schmidt H, Williamson D, Ashley-Koch A. HLA-DR15 haplotype and multiple sclerosis: a HuGE review. Am J Epidemiol. 2006;165:1097–1109.
   Web of Science ®Google Scholar
• Cocco E, Murru R, Costa G, et al. Interaction between HLA-DRB1-DQB1 haplotypes in sardinian multiple sclerosis population. PloS One. 2013;8(4):e59750.
   PubMed Web of Science ®Google Scholar
• Messadi A, Najiba FM, Ouerhani S, et al. HLA Class II alleles and multiple sclerosis in Tunisian patients. Clin Neurol Neurosurg. 2010;112(10):849–852.
   PubMed Web of Science ®Google Scholar
• Rojas OL, Rojas-Villaraga A, Cruz-Tapias P, et al. HLA class II polymorphism in latin American patients with multiple sclerosis. Autoimm Rev. 2010;9(6):407–413.
   PubMed Web of Science ®Google Scholar
• Oksenberg JR, Barcellos LF, Cree BA, et al. Mapping multiple sclerosis susceptibility to the HLA-DR locus in African Americans. Am J Hum Genet. 2004;74(1):160–167.
   PubMed Web of Science ®Google Scholar
• Alves-Leon SV, Papais-Alvarenga R, Magalhaes M, et al. Ethnicity-dependent association of HLA DRB1-DQA1-DQB1 alleles in Brazilian multiple sclerosis patients. Acta Neurol Scand. 2007;115(5):306–311.
   PubMed Web of Science ®Google Scholar
• Anagnostouli MC, Manouseli A, Artemiadis AK, et al. HLA-DRB1* allele frequencies in pediatric, adolescent and adult-onset multiple sclerosis patients, in a hellenic sample. Evidence for new and established associations. J Mult Scler. 2014;1:104.
   Google Scholar
• Katsavos S, Anagnostouli M. Biomarkers in multiple sclerosis: an up-to-date overview. Mult Scler Int. 2013;2013:340508.
   PubMedGoogle Scholar
• Stamatelos P, Anagnostouli M. HLA-genotype in multiple sclerosis: the role in disease onset, clinical course, cognitive status and response to treatment: a clear step towards personalized therapeutics. Immunogenet open access. 2017;2:116.
   Google Scholar
• Laroni A, Calabrese M, Perini P, et al. Multiple sclerosis and autoimmune diseases. Epidemiology and HLA-DR association in North-east Italy. J Neurol. 2006;253:636–639.
   PubMed Web of Science ®Google Scholar
• Moutsianas L, Jostins L, Beecham AH, et al. Class II HLA interactions modulate genetic risk for multiple sclerosis. Nat Genet. 2015;47(10):1107–1113.
   PubMed Web of Science ®Google Scholar
• De Jager PL, Chibnik LB, Cui J, et al. Integrating genetic risk factors into a clinical algorithm for multiple sclerosis susceptibility. Lancet Neurol. 2009;8(12):1111–1119.
   PubMed Web of Science ®Google Scholar
• Gourraud PA, McElroy JP, Caillier SJ, et al. Aggregation of multiple sclerosis genetic risk variants in multiple and single case families. Ann Neurol. 2011;69(1):65–74.
   PubMed Web of Science ®Google Scholar
• International Multiple Sclerosis Genetics Consortium. Low-frequency and rare-coding variation contributes to multiple sclerosis risk. Cell. 2018;175(6):1679–1687.
   PubMed Web of Science ®Google Scholar
• Harbo HF, Isobe N, Berg-Hansen P, et al. Oligoclonal bands and age at onset correlate with genetic risk score in multiple sclerosis. Mult Scler. 2014;20:660–668.
   PubMed Web of Science ®Google Scholar
• Katsavos S, Artemiadis A, Davaki P, et al. Familial multiple sclerosis in Greece: distinct clinical and imaging characteristics in comparison with the sporadic disease. Clin Neurol Neurosurg. 2018;173:144–149.
   PubMed Web of Science ®Google Scholar
• Rojas JI, Patrucco L, Miguez J, et al. Disease onset in familial and sporadic multiple sclerosis in Argentina. Mult Scler Relat Disord. 2016;6:54–56.
   PubMed Web of Science ®Google Scholar
• Bartulos Iglesias M, Marzo Sola ME, Estrella Ruiz LA, et al. Epidemiological study of multiple sclerosis in La Rioja. Neurologia. 2015;30:552–560.
   PubMed Web of Science ®Google Scholar
• Papais-Alvarenga RM, Pereira FF, Bernandes MS, et al. Familial forms of multiple sclerosis and neuromyelitis optica at an MS center in Rio de Janeiro State, Brazil. J Neurol Sci. 2015;356:196–201.
   PubMed Web of Science ®Google Scholar
• Steenhof M, Nielsen NM, Stenager E, et al. Distribution of disease courses in familial vs sporadic multiple sclerosis. Acta Neurol Scand. 2019;139(3):231–237.
   PubMed Web of Science ®Google Scholar
• Da Silva Bernandes M, Antao Paiva CL, Paradela R, et al. Familial multiple sclerosis in a Brazilian sample: Is HLA-DR15 involved in susceptibility to the disease? J Neuroimmunol. 2019;330:74–80.
   PubMed Web of Science ®Google Scholar
• Marsh SG. Nomenclature for factors of the HLA system, update June 2012. Tissue Antigens. 2012;80:289–293.
   PubMedGoogle Scholar
• Papassavas EC, Spyropoulou-Vlachou M, Papassavas AC, et al. MHC class I and class II phenotype, gene, and haplotype frequencies in Greeks using molecular typing data. Hum Immunol. 2000;61:615–623.
   PubMed Web of Science ®Google Scholar
• Benjamini Y, Drai D, Elmer G, et al. Controlling the false discovery rate in behavior genetics research. Behav Brain Res. 2001;125:279–284.
   PubMed Web of Science ®Google Scholar
• Narum SR. Beyond Bonferroni: less conservative analyses for conservation genetics. Conserv Genet. 2006;7:783–787.
   Web of Science ®Google Scholar
• Lancaster AK, Single RM, Solberg OD, et al. PyPop update – a software pipeline for large-scale multilocus population genomics. Tissue Antigens. 2007;69(Suppl 1):192–197.
   PubMedGoogle Scholar
• Herrera BM, Ramagopalan SV, Lincoln MR, et al. Parent-of-origin effects in MS: observations from avuncular pairs. Neurology. 2008;71(11):799–803.
   PubMed Web of Science ®Google Scholar